4-PBA treatments in humans were conducted in adults having cystic fibrosis caused by a ΔF508 CFTR (cystic fibrosis transmembrane conductance regulator) variant, and it led to the partial restoration of chloride transport in the nasal epithelium, with a specific recommended dose range [53]. This evidence concerns the gene CFTR and cystic fibrosis.